Oxidative modifications impair albumin quantification

Biochemical and Biophysical Research Communications

Volumn 401, Issue 1, 2010, Pages 137-142

  Michelis, Regina ^a   Kristal, Batya ^a   Snitkovsky, Tamara ^a   Sela, Shifra ^a  

^a WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

Albumin; Bromocresol green; Carbonyl; Glycoxidation; Hypoalbuminemia

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BROMOCRESOL GREEN; SERUM ALBUMIN;

ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOXIDATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOALBUMINEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; ONCOTIC PRESSURE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; SPECTROPHOTOMETRY;

ADULT; ALBUMINURIA; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CONFORMATION; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 77957676883     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.027     Document Type: Article

References (29)

1. Beddhu S., Kaysen G.A., Yan G., Sarnak M., Agodoa L., Ornt D., Cheung A.K. HEMO Study Group. Association of serum albumin, atherosclerosis in chronic hemodialysis patients. Am. J. Kidney Dis. 2002, 40:721-727.
2. Cooper B.A., Penne E.L., Bartlett L.H., Pollock C.A. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am. J. Kidney Dis. 2004, 43:61-66.
3. Iseki K., Kawazoe N., Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993, 44:115-119.
4. Himmelfarb J., Stenvinkel P., Ikizler T.A., Hakim R.M. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002, 62:1524-1538.
5. Himmelfarb J., McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 2001, 60:358-363.
6. Lim P.S., Cheng Y.M., Yang S.M. Impairments of the biological properties of serum albumin in patients on haemodialysis. Nephrology 2007, 12:18-24.
7. Mera K., Anraku M., Kitamura K., Nakajou K., Maruyama T., Tomita K., Otagiri M. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens. Res. 2005, 28:973-980.
8. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., Jungers P., Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49:1304-1313.
9. Mera K., Anraku M., Kitamura K., Nakajou K., Maruyama T., Otagiri M. The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst. Biochem. Biophys. Res. Commun. 2005, 334:1322-1328.
10. Anraku M., Yamasaki K., Maruyama T., Kragh-Hansen U., Otagiri M. Effect of oxidative stress on the structure and function of human serum albumin. Pharm. Res. 2001, 18:632-639.
11. Danielski M., Ikizler T.A., McMonagle E., Kane J.C., Pupim L., Morrow J., Himmelfarb J. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am. J. Kidney Dis. 2003, 42:286-294.
12. Don B.R., Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin. Dial. 2004, 17:432-437.
13. Michelis R., Sela S., Kristal B. Intravenous iron-gluconate during haemodialysis modifies plasma beta2-microglobulin properties and levels. Nephrol. Dial. Transplant. 2005, 20:1963-1969.
14. Michelis R., Gery R., Sela S., Shurtz-Swirski R., Grinberg N., Snitkovski T., Shasha S.M., Kristal B. Carbonyl stress induced by intravenous iron during haemodialysis. Nephrol. Dial. Transplant. 2003, 18:924-930.
15. Shacter E., Williams J.A., Lim M., Levine R.L. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic. Biol. Med. 1994, 17:429-437.
16. Rashid G., Benchetrit S., Fishman D., Bernheim J. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int. 2004, 66:1099-1106.
17. Himmelfarb J., McMonagle E., McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 2000, 58:2571-2578.
18. Anraku M., Kitamura K., Shinohara A., Adachi M., Suenga A., Maruyama T., Miyanaka K., Miyoshi T., Shiraishi N., Nonoguchi H., Otagiri M., Tomita K. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int. 2004, 66:841-848.
19. Ballmer P.E., McNurlan M.A., Hulter H.N., Anderson S.E., Garlick P.J., Krapf R. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J. Clin. Invest. 1995, 95:39-45.
20. Pereira B.J., Shapiro L., King A.J., Falagas M.E., Strom J.A., Dinarello C.A. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int. 1994, 45:890-896.
21. Kaysen G.A. Biological basis of hypoalbuminemia in ESRD. J. Am. Soc. Nephrol. 1998, 9:2368-2376.
22. Himmelfarb J. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiol. Clin. 2005, 23:319-330.
23. Meydani M. Nutrition interventions in aging and age-associated disease. Ann. N.Y. Acad. Sci. 2001, 928:226-235.
24. Greenblatt D.J. Reduced serum albumin concentration in the elderly: a report from the Boston collaborative drug surveillance program. J. Am. Geriatr. Soc. 1979, 27:20-22.
25. Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 2004, 24:816-823.
26. Folsom A.R., Ma J., Eckfeldt J.H., Nieto F.J., Metcalf P.A., Barnes R.W. Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann. Epidemiol. 1995, 5:186-191.
27. Roy D., Quiles J., Gaze D.C., Collinson P., Kaski J.C., Baxter G.F. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006, 92:113-114.
28. Guven S., Alver A., Mentese A., Ilhan F.C., Calapoglu M., Unsal M.A. The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies. Acta Obstet. Gynecol. Scand. 2009, 88:479-482.
29. Talmor Y., Golan E., Benchetrit S., Bernheim J., Klein O., Green J., Rashid G. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am. J. Physiol. Renal. Physiol. 2008, 294:F1059-1064.